Screener
Intellia Therapeutics NTLA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsAndOtherNoncurrentAssets.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities - noncurrent | 190,595 | 155,250 |
| Property and equipment, net | 15,058 | 17,671 |
| Operating lease right-of-use assets | 85,954 | 105,955 |
| Investments and other assets | 37,725 | 35,540 |
| Total assets | $857,164 | $842,127 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $11,714 | $20,252 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's other non-current assets?
- Intellia Therapeutics (NTLA) reported other non-current assets of $37.73M in Q2 2026.
- How has Intellia Therapeutics's other non-current assets changed year-over-year?
- Intellia Therapeutics's other non-current assets decreased by 53.0% year-over-year, from $80.24M to $37.73M.
- What is the long-term trend for Intellia Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), Intellia Therapeutics's other non-current assets has grown at a 49.6% compound annual growth rate (CAGR), from $4.75M to $35.54M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Intellia Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude